NYSE
Danaher Corporation (DHR)
♥ 401 Thanks from members
Danaher Corporation (DHR) demonstrates resilient financial health with expanded EBITDA margins and steady life sciences growth, though sentiment remains tempered by bioprocessing lumpy demand, China revenue headwinds, and Masimo M&A headline risks.